Table 2.
Epidemiological features of included articles
| Author | Age (years), mean (SD) | Age (years), range | Sex (males), n (%) | Time to diagnosis (months), mean (SD) | Time to diagnosis (months), range | HIV infection, n (%)a | Previous pulmonary TB, n (%) |
|---|---|---|---|---|---|---|---|
| Prazuck et al. [33] | 34 (−) | 1–78 | 26 (58) | - | - | - | - |
| Campos et al. [34] | - | 0.5–14 | 14 (52) | 8 (−) | 0–84 | - | - |
| Richter et al. [35] | - | - | - | - | - | - | - |
| Fam et al. [36] | 52 (−) | 26–74 | 2 (29) | 12b | 5–30 | 0/2 (0) | 1 (14) |
| Puigdengolas et al. [37] | 58 (−) | 21–85 | 10 (71) | 6 (4) | - | - | 8 (57) |
| Leibert et al. [38] | 43 (15) | 24–63 | 5 (71) | 3 (−) | 0–24 | 7/7 (100) | - |
| Pertuiset et al. [25] | 41b | 17–84 | 68 (66) | 4 (−) | 0–36 | 0/54 (0) | 19 (18) |
| Barrière et al. [10] | 42 (−) | 20–76 | 9 (56) | 3 (−) | 1–6 | 0/16 (0) | - |
| Alothman et al. [39] | 53 (−) | 15–80 | 37 (53) | - | - | - | 5 (7) |
| Solagberu et al. [40] | 27 (23) | 2–70 | 24 (48) | - | - | - | - |
| Garcia-Lechuz et al. [41] | 58 (−) | - | 9 (64) | - | 1 – 36 | 1/14 (7) | - |
| Rasit et al. [11] | 40 (−) | - | 37 (70) | 7 (−) | - | - | - |
| Rodriguez-Gómez et al. [42] | 60 (14) | 24–82 | 19 (51) | 7 (7) | 1–32 | Excluded | 8 (22) |
| Meddeb et al. [43] | 49 (−) | - | 14 (48) | 7 (−) | - | - | - |
| Sakho et al. [44] | 35 (−) | 1–80 | 136 (53) | 11 (−) | 1–120 | 1/37 (3) | - |
| Dharmalingam et al. [45] | 34 (−) | 3–76 | 24 (73) | - | - | - | - |
| Colmenero et al. [12] | 49 (19) | 14–84 | 40 (51) | 6 (−) | 0–7 | 6 (8) | - |
| Schlesinger et al. [13] | 40 (−) | 19–67 | 7 (58) | - | 2–48 | 1/12 (8) | - |
| López Cordoba et al. [46] | - | 1–71 | 23 (49) | 9 (−) | 1–60 | 0/24 (0) | - |
| Mulleman et al. [3] | 61 (−) | - | 9 (38) | 4 (−) | 1–12 | 0 (0) | 4/24 (17) |
| Sharifi-Mood et al. [47] | 29 (24) | 4–73 | 82 (70) | - | - | - | - |
| Tasova et al. [48] | 45 (19) | 18–80 | 20 (50) | 12 (12) | 1–28 | - | - |
| Kotil et al. [49] | 42 (−) | 10–70 | 21 (48) | - | - | - | - |
| Park et al. [14] | 44 (17) | - | 69 (50) | - | - | - | - |
| Godlwana et al. [50] | 28 (−)c | - | 43 (42) | - | - | 29/104 (28) | 104 (100) |
| Maeda et al. [15] | 76 (−) | 70–92 | 10 (44) | 5 (−) | 1–24 | - | - |
| Kenyon et al. [51] | 29 (−) | 14–65 | 8 (47) | 7b (−) | 0–24 | - | - |
| Polley et al. [5] | 34 (21) | 12–68 | 7 (44) | - | - | 1/12 (8) | - |
| Owolabi et al. [21] | 41 (15) | 15–70 | 57 (66) | 75 % > 2 months | - | 15/87 (17) | 10 (12) |
| Su et al. [16] | 64 (16) | 10–88 | 24 (50) | 7 (6) | 1–24 | 1 (2) | 4 (8) |
| Weng et al. [17] | 68 (−) | 36–86 | 23 (61) | 3 (−) | 0–24 | Excluded | 2 (5) |
| Benzagmout et al. [52] | 9 (−) | 4–15 | 24 (64) | 9 (−) | 0–48 | - | 0 (0) |
| Kim et al. [53] | 56 (−) | - | 17 (36) | 4 (−) | - | - | 6 (13) |
| Mwachaka et al. [54] | 34 (16) | 3–81 | 68 (53) | - | - | 0 (0) | - |
| Alavi et al. [55] | 44 (18) | - | 42 (61) | 7 (4) | - | 12/69 (17) | - |
| Lozano et al. [56] | 54 (−) | - | 2 (33) | 7 (−) | 1–20 | 2/6 (33) | - |
| Fedoul et al. [57] | 43 (−) | 4–73 | 38 (46) | 10 (−) | - | - | - |
HIV human immunodeficiency virus, TB tuberculosis, SD standard deviation
a Percentage over realised test
b Data are expressed by median
c Mean age for adults ≥18 years